Bluebird bio Inc

Bluebird bio Inc

BLUE - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$48.67M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bluebird bio IncBluebird bio Inc-0.2-346%0.5-2.7
$3.82

Current Fair Value

23.1% downside

Overvalued by 23.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$48.67 Million
Enterprise Value$128.01 Million
Earnings per Share$-24.84
Beta0.37
Outstanding Shares9,751,000

Return

Return on Equity345.59%ROE
Return on Assets-67.57%
Return on Invested Capital1060.71%

Valuation & Multiples

P/E Ratio-0.2P/E Ratio
PEG0.34PEG
Price to Sales0.5Price to Sales
Price to Book Ratio-0.83Price to Book Ratio
Enterprise Value to Revenue1.23
Enterprise Value to EBIT-0.63
Enterprise Value to Net Income-1
Total Debt to Enterprise1.23
Debt to Equity-2.73Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Bluebird bio Inc

Bluebird bio Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.